116 related articles for article (PubMed ID: 7016930)
1. Lofexidine in the treatment of hypertension: a twice-daily versus one-daily dose comparison with 24-hour blood pressure monitoring.
Garrett BN; Kaplan NM
J Clin Pharmacol; 1981 Apr; 21(4):173-80. PubMed ID: 7016930
[TBL] [Abstract][Full Text] [Related]
2. Changes in blood pressure, plasma catecholamines and plasma renin activity during and after treatment with tiamenidine and clonidine.
Hansson BG; Hökfelt B
Br J Clin Pharmacol; 1981 Jan; 11(1):73-7. PubMed ID: 7011348
[TBL] [Abstract][Full Text] [Related]
3. Lofexidine and clonidine in moderate essential hypertension.
Wilkins LH; Winternitz SR; Oparil S; Smith LR; Dustan HP
Clin Pharmacol Ther; 1981 Dec; 30(6):752-07. PubMed ID: 7030578
[TBL] [Abstract][Full Text] [Related]
4. Centrally acting antihypertensive agents: a comparison of lofexidine with clonidine.
Schultz HS; Chretien SD; Brewer DD; Eltorai MI; Weber MA
J Clin Pharmacol; 1981; 21(2):65-71. PubMed ID: 7229119
[TBL] [Abstract][Full Text] [Related]
5. Effects of dividing amlodipine daily doses on trough drug concentrations and blood pressure control over a 24-hour period.
Miyoshi K; Okura T; Nagao T; Masanori J; Irita J; Higaki J
Clin Ther; 2013 Sep; 35(9):1418-22. PubMed ID: 23972579
[TBL] [Abstract][Full Text] [Related]
6. Assessing duration of antihypertensive effects with whole-day blood pressure monitoring.
Cheung DG; Gasster JL; Weber MA
Arch Intern Med; 1989 Sep; 149(9):2021-5. PubMed ID: 2673118
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamic effect of lofexidine with a diuretic in hypertension.
Vlachakis ND; Velasquez M; Alexander N; Maronde RF
Clin Pharmacol Ther; 1983 Dec; 34(6):764-9. PubMed ID: 6357591
[TBL] [Abstract][Full Text] [Related]
8. Home blood pressure monitoring and changes in plasma catecholamines during once or twice daily treatment with atenolol in patients with mild hypertension.
McGrath BP; Beilin LJ; Schofield T; Benedict CR; Barker NP; Cooper R
Aust N Z J Med; 1979 Aug; 9(4):374-81. PubMed ID: 389223
[TBL] [Abstract][Full Text] [Related]
9. Antihypertensive effects of lofexidine in patients with essential hypertension.
Fagan TC; Bloomfield SS; Cowart TD; Corns-Hurwitz RH; Lipicky RJ; Conradi EC; Hsu CY; Grossman WJ; Harmon GE; Degenhart WJ; Sinkfield AW; Gaffney TE
Br J Clin Pharmacol; 1982 Mar; 13(3):405-10. PubMed ID: 7059442
[TBL] [Abstract][Full Text] [Related]
10. Comparative efficacy and safety of lofexidine and clonidine in mild to moderately severe systemic hypertension.
Lopez LM; Mehta JL
Am J Cardiol; 1984 Mar; 53(6):787-90. PubMed ID: 6702628
[TBL] [Abstract][Full Text] [Related]
11. Twenty-four-hour ambulatory blood pressure evaluation of antihypertensive agents.
Zanchetti A
J Hypertens Suppl; 1997 Dec; 15(7):S21-5. PubMed ID: 9532517
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of once-daily urapidil treatment in mild or moderate essential hypertension assessed by ambulatory 24-hour blood pressure monitoring.
Trimarco B; Rosiello G; Feldhaus P; Steinijans VW; Vecchione F; Cuocolo A; Lembo G; Volpe M
Drugs; 1988; 35 Suppl 6():173-81. PubMed ID: 3402355
[TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind comparison of the antihypertensive efficacy and safety of once-daily losartan compared to twice-daily captopril in mild to moderate essential hypertension.
Roca-Cusachs A; Oigman W; Lepe L; Cifkova R; Karpov YA; Harron DW
Acta Cardiol; 1997; 52(6):495-506. PubMed ID: 9542575
[TBL] [Abstract][Full Text] [Related]
14. Enalapril in low-renin essential hypertension.
Wilkins LH; Dustan HP; Walker JF; Oparil S
Clin Pharmacol Ther; 1983 Sep; 34(3):297-302. PubMed ID: 6309461
[TBL] [Abstract][Full Text] [Related]
15. The efficacy and tolerance of one or two daily doses of eprosartan in essential hypertension. The Eprosartan Multinational Study Group.
Hedner T; Himmelmann A
J Hypertens; 1999 Jan; 17(1):129-36. PubMed ID: 10100104
[TBL] [Abstract][Full Text] [Related]
16. Transdermal clonidine therapy in hypertensive patients. Effects on office and ambulatory recorded blood pressure values.
Schaller MD; Nussberger J; Waeber B; Porchet M; Brunner HR
JAMA; 1985 Jan; 253(2):233-5. PubMed ID: 3965774
[TBL] [Abstract][Full Text] [Related]
17. Plasma renin activity, blood pressure and sodium excretion during treatment with clonidine.
Fyhrquist F; Kurppa K; Huuskonen M
Acta Med Scand; 1975 Jun; 197(6):457-61. PubMed ID: 1155220
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the safety and efficacy of once-daily terazosin versus twice-daily prazosin for the treatment of mild to moderate hypertension.
Deger G
Am J Med; 1986 May; 80(5B):62-7. PubMed ID: 2872809
[TBL] [Abstract][Full Text] [Related]
19. Clonidine-chlorthalidone combination once and twice daily in essential hypertension.
Noveck RJ; McMahon FG; Jain AK; Ryan JR
Clin Pharmacol Ther; 1980 Nov; 28(5):581-6. PubMed ID: 7438676
[TBL] [Abstract][Full Text] [Related]
20. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
de Champlain J; Karas M; Nguyen P; Cartier P; Wistaff R; Toal CB; Nadeau R; Larochelle P
J Hypertens; 1998 Nov; 16(11):1357-69. PubMed ID: 9856375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
